QUESTCOR PHARMACEUTICALS INC 4
4 · QUESTCOR PHARMACEUTICALS INC · Filed Mar 19, 2014
Insider Transaction Report
Form 4
Medeiros David Jeffrey
Snr VP Pharmaceutical Ops
Transactions
- Exercise/Conversion
Common Stock
2014-03-17$35.78/sh+1,250$44,725→ 122,330 total - Exercise/Conversion
Stock Option (right to buy)
2014-03-17−1,250→ 28,750 totalExercise: $35.78Exp: 2022-02-14→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2014-03-17$14.24/sh+1,041$14,824→ 121,080 total - Sale
Common Stock
2014-03-17$62.36/sh−1,664$103,769→ 120,666 total - Sale
Common Stock
2014-03-17$63.25/sh−627$39,660→ 120,039 total - Exercise/Conversion
Stock Option (right to buy)
2014-03-17−1,041→ 11,459 totalExercise: $14.24Exp: 2021-02-15→ Common Stock (1,041 underlying)
Footnotes (4)
- [F1]Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
- [F2]The option was granted on 02/16/2011 for the right to buy 50,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
- [F3]The option was granted on 02/15/2012 for the right to buy 60,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00-$62.79 and $63.02-63.68, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.